Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
2(17%)
Results Posted
25%(2 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
10
83%
Ph phase_1
1
8%
Ph phase_2
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
N/ANon-phased studies
10(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(8)
Terminated(2)

Detailed Status

Completed8
Active, not recruiting1
Terminated1
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
88.9%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (8.3%)
Phase 21 (8.3%)
N/A10 (83.3%)

Trials by Status

active_not_recruiting18%
completed867%
terminated18%
withdrawn18%
recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12